Is a complete SHE/300401 research report available?

No complete published report is available for she/300401 (SHE/300401) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/300401 stock profile: metrics, valuation and analysis

Market cap	8B
Revenue (ttm)	1.3B
Net income (ttm)	275.2M
EPS (ttm)	CN¥0.46
Shares out	544.8M
P/E (trailing)	31.9x
P/E (forward)	18.4x
Dividend	CN¥0.11 (0.73%)
Volume	44,068,480
Beta	0.46

All SHE/300401 indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,163
Employees Change	142%
Employees Change Percent	13.91
Enterprise value	CNY 8.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	35.4
Industry PE Fwd	17.7
Isin	CNE100001XX7
Last refreshed	2026-09-07
Market cap	CNY 8B
Price	CNY 14.75
Price currency	CNY
Rev Per Employee	1,112,764.33x
Sector	Healthcare
Sector PE	40.46
Sector PE Fwd	21.01
Sic	2834
Symbol	she/300401
Website	https://www.hybiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.43%
EV Earnings	30.91x
EV/EBIT	25.03x
EV/EBITDA	16.26x
EV/FCF	78.47x
EV/Sales	6.57x
FCF yield	1.35%
Forward P/E	18.44x
P/B ratio	2.25x
P/E ratio	31.94x
P/S ratio	6.21x
PE Ratio10 Y	38.03x
PE Ratio3 Y	29.65x
PE Ratio5 Y	26.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.26%
EBITDA Margin	40.41%
FCF margin	8.38%
Gross margin	49.57%
Gross Profit	CNY 641.5M
Gross Profit Growth	-12.44%
Gross Profit Growth Q	6.03%
Gross Profit Growth3 Y	-6.44%
Gross Profit Growth5 Y	4.18%
Net Income	CNY 275.2M
Net Income Growth	-16.25%
Net Income Growth Q	25.55%
Net Income Growth Qo Q	62.42%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	10.52%
Net Income Growth5 Y	-8.11%
Pretax Margin	24.46%
Profit Margin	21.27%
Profit Per Employee	CNY 236,665
Profitable Quarters	CNY 43
Profitable Years	18
ROA	3.66
Roa5y	4.84
ROCE	7.08
ROE	7.95
Roe5y	12.39
ROIC	7.69
Roic5y	11.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.15%
Cagr1y	3.55%
Cagr3y	9.17%
Cagr5y	0.89%
Div CAGR10	34.12%
Div CAGR3	-6.89%
Div CAGR5	1.87%
EPS Growth	-19.33
EPS Growth Q	31.77
EPS Growth Qo Q	54.14
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	8.06
EPS Growth5 Y	-9.98
FCF Growth	44.49%
OCF Growth	-28.92%
OCF Growth10 Y	31.28%
OCF Growth3 Y	27.52%
OCF Growth5 Y	0.48%
Revenue Growth	1.23x
Revenue Growth Q	34.39x
Revenue Growth Qo Q	49.96x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	0.53x
Revenue Growth5 Y	8.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.22
Assets	CNY 5.9B
Cash	CNY 1.4B
Current Assets	CNY 2.5B
Current Liabilities	CNY 1.1B
Debt	CNY 1.8B
Debt EBITDA	CNY 3.51
Debt Equity	CNY 0.51
Debt FCF	CNY 16.96
Equity	CNY 3.6B
Interest Coverage	10.56
Liabilities	CNY 2.4B
Long Term Assets	CNY 3.5B
Long Term Liabilities	CNY 1.2B
Net Cash	CNY -470.5M
Net Cash By Market Cap	CNY -5.86
Net Debt EBITDA	CNY 0.9
Net Debt Equity	CNY 0.13
Net Debt FCF	CNY 4.34
Tangible Book Value	CNY 3.3B
Tangible Book Value Per Share	CNY 6.14
WACC	5.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.18
Inventory Turnover	0.87
Net Working Capital	CNY 659.5M
Quick ratio	1.42
Working Capital	CNY 1.3B
Working Capital Turnover	CNY 1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.82%
Dividend Growth	-0.88%
Dividend Growth Years	1%
Dividend per share	CNY 0.11
Dividend Years	6
Dividend Yield	0.73%
Ex Div Date	2026-05-27
Last Dividend	CNY 0.11
Payout Frequency	Annual
Payout Ratio	35.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	50.1%
1Y total return	3.54%
200-day SMA	15.11
3Y total return	30.11%
50-day SMA	15.26
50-day SMA vs 200-day SMA	50over200
5Y total return	4.55%
All Time High	25.59
All Time High Change	-42.36%
All Time High Date	2018-05-23
All Time Low	1.85
All Time Low Change	697.3%
All Time Low Date	2014-10-09
ATR	0.95
Beta	0.46
Beta1y	0.28
Beta2y	0.55
Ch YTD	-2.45
High	15.3
High52	23.44
High52 Date	2026-06-26
High52ch	-37.07%
Low	14.61
Low52	10.68
Low52 Date	2026-06-09
Low52ch	38.11%
Ma50ch	-3.31%
Price vs 200-day SMA	-2.35%
RSI	49.93
RSI Monthly	50.17
RSI Weekly	49.43
Sharpe ratio	0.13x
Sharpe Ratio3y	0.32x
Sharpe Ratio5y	0.2x
Sortino ratio	0.31
Sortino Ratio3y	0.62
Sortino Ratio5y	0.45
Total Return	-3.09%
Tr YTD	-1.59
Tr1m	17.53%
Tr1w	-0.34%
Tr3m	25.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	359,890,914%
Net Borrowing	33,799,722
Shares Insiders	5.12%
Shares Institutions	2.83%
Shares Out	544,816,618
Shares Qo Q	5.38%
Shares Yo Y	3.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	33,723,479.25x
Bv Per Share	6.56
CAPEX	CNY -286.2M
Ch10y	40.21
Ch1m	17.53
Ch1w	-0.34
Ch1y	2.64
Ch3m	25.43
Ch3y	27.27
Ch5y	-0.34
Ch6m	-9.68
Change	-4.96%
Change From Open	-3.47
Close	15.52
Days Gap	-1.55
Depreciation Amortization	183,155,016
Dollar Volume	650,010,080
Earnings Date	2026-08-15
EBIT	CNY 339.8M
EBITDA	CNY 523M
EPS	CNY 0.46
F Score	5
FCF	CNY 108.4M
FCF EV Yield	1.27x
FCF Per Share	CNY 0.2
Financing CF	-64,363,309
Fiscal Year End	December
Founded	2,000
Graham Number	8.25733
Graham Upside	-44.02
Income Tax	CNY 41.3M
Investing CF	20,336,330
Is Primary Listing	1
Last Earnings Date	2026-08-15
Last Report Date	2026-06-30
Last Split Date	2018-05-04
Last Split Type	Forward
Lynch Fair Value	CNY 2.31
Lynch Upside	-84.35
Ma150	15.11
Ma150ch	-2.41%
Ma20	15.03
Ma20ch	-1.86%
Net CF	340,178,686
Next Earnings Date	2026-10-19
Open	15.28
P FCF Ratio	74.13
P OCF Ratio	20.36
Payment Date	2026-05-27
Position In Range	20.29
Ppne	3,077,139,130
Price Date	2026-09-04
Price EBITDA	CNY 15.37
Ptbv Ratio	2.4
Relative Volume	1.33x
Revenue	1,294,144,913x
Tax By Revenue	3.19x
Tax Rate	13.04%
Tr6m	-8.88%
Volume	44,068,480
Z Score	3.42

SHE/300401 (SHE/300401)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300401

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300401 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/300401

Frequently asked questions